Data / Form D filings / Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc.: Form D filings
Transposon Therapeutics, Inc., a pharmaceuticals company in San Diego, CA, filed 5 Form D notices with the SEC between 2020 and 2024. The latest, on July 15, 2024, reports $4.7 million sold of a $20 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4660 La Jolla Village Drive, Suites 100 & 200, San Diego, CA, 92112
- Phone
- (949) 422-9676
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1810705
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 15, 2024 | New notice | $20,000,000 | $4,679,395 | $15,320,605 | 8 | Jul 10, 2024 | sec.gov |
| Jan 12, 2023 | Amendment | $20,020,000 | $5,005,000 | $15,015,000 | 8 | Dec 20, 2022 | sec.gov |
| Dec 29, 2022 | New notice | $20,020,000 | $0 | $20,020,000 | 8 | Dec 20, 2022 | sec.gov |
| Dec 9, 2020 | New notice | $45,187,328 | $45,187,328 | 10 | Nov 25, 2020 | sec.gov | |
| May 6, 2020 | New notice | $6,500,000 | $4,250,000 | $2,250,000 | 4 | Apr 21, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Keith A. Katkin | Director | |
| Dennis Taylor Podlesak | Executive Officer, Director | |
| Lynne R. Rollins | Executive Officer | |
| Daniel R. Hetu, MD, MBA | Director | |
| Eckard R. Weber, MD | Executive Officer, Director | |
| Brent R. Ahrens | Director | |
| Brian Taylor Slingsby, MD, PHD, MPH | Director | |
| William R. Harrington, MD, MBA | Director | |
| John R. Pacifico | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jul 15, 2024 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Transposon Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.